Medicare Enrolled
Dr. Dinesh Arab, M.D.
Cardiovascular Disease · Daytona Beach, FL
Practice pattern: Cardiac & Electrophysiology— Practice combining cardiac and electrophysiology services
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Arab from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Arab? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Arab
Dr. Dinesh Arab is a cardiovascular disease in Daytona Beach, FL, with 19 years in practice. Based on federal Medicare data, Dr. Arab performed 11,124 Medicare services across 7,465 unique beneficiaries.
Between the years covered by Open Payments, Dr. Arab received a total of $120,372 from 60 pharmaceutical and/or device companies across 1056 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Arab is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 6% volume in FL$ $120,372 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,124
Medicare services
Top 6% in FL for cardiovascular disease
7,465
Unique beneficiaries
$113
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~585 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 1,757 | $90 | $219 |
| Regadenoson injection (Lexiscan) for heart stress test | 1,365 | $43 | $486 |
| Electrocardiogram (EKG), 12-lead | 1,079 | $11 | $31 |
| EKG interpretation and report | 952 | $6 | $25 |
| Echocardiogram, transthoracic | 817 | $143 | $417 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 459 | $50 | $148 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 409 | $357 | $780 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 388 | $318 | $848 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 365 | $28 | $81 |
| Remote pacemaker/defibrillator monitoring, 90 days | 334 | $17 | $50 |
| Remote pacemaker monitoring, 90 days | 237 | $23 | $55 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 229 | $20 | $50 |
| Hospital follow-up visit, moderate complexity | 215 | $63 | $127 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 206 | $328 | $958 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 193 | $1,185 | $3,204 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 192 | $20 | $37 |
| New patient office visit (45-59 min) | 192 | $121 | $287 |
| Hospital follow-up visit, low complexity | 183 | $41 | $76 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 173 | $620 | $1,234 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 141 | $20 | $49 |
| Nuclear medicine study of heart muscle blood flow by pet | 129 | $142 | $382 |
| Initial hospital admission, moderate complexity | 114 | $103 | $243 |
| Programming of dual lead pacemaker system | 107 | $58 | $168 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 100 | $28 | $80 |
| Ultrasound of heart with probe in esophagus, with report | 100 | $81 | $239 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 76 | $10 | $85 |
| Ultrasound of both sides of head and neck blood flow | 69 | $147 | $412 |
| Replacement of aortic valve through the skin and femoral artery | 43 | $630 | $1,834 |
| Initial hospital admission, high complexity | 43 | $134 | $358 |
| Cardiac catheterization | 39 | $218 | $640 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 39 | $66 | $158 |
| Hospital follow-up visit, high complexity | 38 | $96 | $213 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 34 | $2 | $10 |
| Ultrasound of heart, follow-up | 31 | $20 | $75 |
| Ultrasound of heart blood flow, valves and chambers | 31 | $14 | $53 |
| Office visit, established patient (20-29 min) | 31 | $32 | $136 |
| Programming of multiple lead implantable defibrillator system | 25 | $76 | $223 |
| Programming of cardiac rhythm monitor system | 23 | $45 | $85 |
| Ultrasound of heart | 22 | $35 | $131 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 22 | $300 | $810 |
| Office visit, established patient (10-19 min) | 22 | $17 | $72 |
| New patient office visit (30-44 min) | 19 | $62 | $170 |
| Repair of left upper heart chamber with implant with review by radiologist | 18 | $631 | $1,203 |
| Ultrasound of leg arteries or artery grafts | 17 | $173 | $536 |
| Office visit, established patient, complex (40-54 min) | 17 | $143 | $350 |
| External shock to heart to regulate heart beat | 16 | $82 | $229 |
| Hospital discharge day management, 30 minutes or less | 13 | $65 | $174 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
15.9% high complexity
23.3% medium
60.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$120,372
Total received (2018-2024)
Avg $17,196/year across 7 years
Top 4% in FL for cardiovascular disease
60
Companies
1,056
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$93,880 (78.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,795 (18.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,697 (3.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$16,700
2023$14,613
2022$10,139
2021$5,893
2020$23,614
2019$29,456
2018$19,956
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic Vascular, Inc.
$39,459
Medtronic, Inc.
$29,448
Cardiovascular Systems Inc.
$18,463
Abbott Laboratories
$8,297
Amgen Inc.
$6,921
CVRx, Inc.
$5,164
Edwards Lifesciences Corporation
$1,853
Boston Scientific Corporation
$1,568
Janssen Pharmaceuticals, Inc
$1,498
ABIOMED
$970
Boehringer Ingelheim Pharmaceuticals, Inc.
$787
PFIZER INC.
$602
Astellas Pharma US Inc
$560
SANOFI-AVENTIS U.S. LLC
$483
Medical Device Business Services, Inc.
$473
Novartis Pharmaceuticals Corporation
$364
Merck Sharp & Dohme LLC
$317
Penumbra, Inc.
$290
Amarin Pharma Inc.
$246
E.R. Squibb & Sons, L.L.C.
$242
Kestra Medical Technology Services, Inc.
$163
Gilead Sciences, Inc.
$163
AstraZeneca Pharmaceuticals LP
$162
ATRICURE, INC.
$150
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$137
Inari Medical, Inc.
$125
LivaNova USA, Inc.
$116
Impulse Dynamics (USA) Inc.
$96
Kowa Pharmaceuticals America, Inc.
$94
Philips North America LLC
$88
BOSTON SCIENTIFIC CORPORATION
$86
Esperion Therapeutics, Inc.
$76
Regeneron Healthcare Solutions, Inc.
$74
Braemar Manufacturing, LLC
$71
Novo Nordisk Inc
$71
iRhythm Technologies, Inc.
$67
Opsens Inc.
$50
ARBOR PHARMACEUTICALS, INC.
$48
Biosense Webster, Inc.
$48
BIOTRONIK INC.
$47
AngioDynamics, Inc.
$46
Cleerly, Inc.
$45
Philips Electronics North America Corporation
$36
ZOLL Circulation Inc
$29
Alnylam Pharmaceuticals Inc.
$28
HEARTFLOW, INC.
$28
Acist Medical Systems, Inc.
$26
Bardy Diagnostics, Inc.
$22
AtriCure, Inc.
$20
AltaThera Pharmaceuticals LLC
$18
PORTOLA PHARMACEUTICALS, INC.
$18
BSN Medical Inc
$16
Circassia Pharmaceuticals Inc
$15
Teleflex LLC
$15
Siemens Medical Solutions USA, Inc.
$14
Terumo Medical Corporation
$13
G Medical Diagnostic Services, Inc.
$12
ARALEZ PHARMACEUTICALS US INC.
$12
W. L. Gore & Associates, Inc.
$12
Allergan Inc.
$12
Top 3 companies account for 72.6% of total payments
Associated products mentioned in payments ›
(7999) SRC Undivided · (BS0) Mechanical Atherectomy · (CM9) Amb Mon & Diag Und · ABRE · ABSOLUTE PRO · ALPHAVAC · AMPLATZER AMULET · AMPLATZER Occluders · AMPLATZER TALISMAN · ATRICLIP LAA EXCLUSION SYSTEM · AVEIR · AVIVO · Acunav · Advisa · Artis pheno · Assure WCD · Azure · BEVYXXA · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CARDIOMEMS · CLOSUREFAST · COMET · COREVALVE EVOLUT R · CVI Systems · Cardiac Monitoring Suite · CardioMEMS HF System · CareLink Express · Carnation Ambulatory Monitor · Carto 3 System · Cleerly Ischemia · Consulta · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · DIAMONDBACK CORONARY · DIAMONDBACK PERIPHERAL · Diamondback Coronary · Diamondback Peripheral · DxTerity · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edarbyclor · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FFRct · FLOWTRIEVER CATHETER · FilterWire EZ · FlowTriever · GENERAL ATHERECTOMY · GORE CARDIOFORM Septal Occluder · General - Atherectomy · General - Stents · General - Therapies · HAWKONE · HawkOne · HeartMate · IN.PACT ADMIRAL · IN.PACT Admiral · INNOVA · Impella · Indigo System · JARDIANCE · JETI · JOBST SPORT · LEQVIO · LEXISCAN · LIFESPARC · LOKELMA · LifeVest · Livalo · MICRA · MITRACLIP · MULTAQ · Merlin Connectivity and Remote · Micra · Mitra Clip system · NEXLETOL · NUVISION ICE CATHETER · ONPATTRO · OPTIMIZER · Optimizer · Optimizer Smart System · OptoWire · Ozempic · PASCAL · PERCLOSE PROGLIDE · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PROTEKDUO · Peripheral Orbital Atherectomy System · PressureWire FFR · Prolia · ProtekDuo Kit · Quadra Assura CRT Defibrillator · Repatha · Resolute · Reveal LINQ · Rybelsus · S · SAPIEN 3 Ultra RESILIA · SPIDERFX · STIOLTO RESPIMAT · Sotalol Hydrochloride · SpiderFX · Supera peripheral stent system · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TRAPLINER · TUDORZA PRESSAIR · TYRX · Temperature Management System · TherOx DS2 Console · Trilogy 100 · VADO · VERQUVO · VYNDAQEL · Varithena Administration Pack · Vascepa · Viva · WATCHMAN · WATCHMAN Access System · Wegovy · XARELTO · Xience Sierra Coronary Stent · ZIO Patch · ZIO XT Patch · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (78%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for cardiovascular disease in FL.
Equivalent to $1,082 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
32
Per 100K population
5.6
County median income
$66,581
Nearest hospital
ADVENTHEALTH DAYTONA BEACH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Arab is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 6% in FL), and high industry engagement (speaking/promotional, top 4%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Arab experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Arab performed 1,757 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Arab receive payments from pharmaceutical companies?
Yes. Dr. Arab received a total of $120,372 from 60 companies across 1,056 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Arab's costs compare to other cardiovascular diseases in Daytona Beach?
Dr. Arab's average Medicare payment per service is $113. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Arab) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Daytona Beach
Browse cardiovascular diseases in Daytona Beach ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc..
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc..
By company
Cardiovascular Systems Inc. Payments to Doctors
See all physicians who received payments from Cardiovascular Systems Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology